Salomon & Ludwin, LLC: EFIV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Salomon & Ludwin, LLC on EFIV, newest first. How the timeline and the estimate are built.
Salomon & Ludwin, LLC held 383 EFIV shares at 2026-06-30 per its 13F-HR filed 2026-08-07.
the latest 13F is the newest step
- period ended2026-06-3013F 383 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $27,779.
13F-HR 0001766156-26-000005 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 383 sharesChange vs previous 13F +207 shares
<0.01% of the 13F portfolio, value $24,397.
13F-HR 0001766156-26-000003 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 176 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $11,736.
13F-HR 0001766156-26-000002 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 176 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $11,264.
13F-HR 0001766156-25-000008 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 176 sharesChange vs previous 13F 0 shares
<0.01% of the 13F portfolio, value $10,349.
13F-HR 0001766156-25-000007 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 176 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $9,416.
13F-HR 0001766156-25-000005 filed by Salomon & Ludwin, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).